| Conferences \ Targeted Cancer Therapies & Biofluid Biopsies \ Agenda \ Swapna Chaudhuri |
| Register | Login |
The Multi-Potent Novel Biomolecule T11 Target Structure (T11TS) helps in Malignant Glioma Abrogation: A Preclinical StudyFriday, 26 May 2017 at 10:00  Add to Calendar ▼2017-05-26 10:00:002017-05-26 11:00:00Europe/LondonThe Multi-Potent Novel Biomolecule T11 Target Structure (T11TS) helps in Malignant Glioma Abrogation: A Preclinical StudyTargeted Cancer Therapies and Biofluid Biopsies in BengaluruBengaluruSELECTBIOenquiries@selectbiosciences.comThe Presenter will discuss their work on Glioblastoma and will show how Immunotherapy with T11TS (a glycopeptide derived from SRBC) on an established rat model of glioma rejuvenates the deserted immune system and causes profound immune potentiation both at the peripheral and intracranial levels. It will also discuss how T11TS, when administered in three doses to glioma-bearing rats, helps in glioma abrogation by reversing the glioma-induced changes in the T-cell signaling pathway and by steering the pathway in the positive direction. To unearth the root of this immune suppression due to glioma, the modulation of hematopoietic stem cells and their apoptotic death were also studied which will be covered during the talk. Modulation of HSCc during glioma and treatment with T11TS therapy indicates the regenerative power of T11TS.Taken together, the talk will highlight their findings which suggest that T11TS can be introduced as an effective anti- neoplastic agent. |
Add to Calendar ▼2017-05-25 00:00:002017-05-26 00:00:00Europe/LondonTargeted Cancer Therapies and Biofluid BiopsiesTargeted Cancer Therapies and Biofluid Biopsies in BengaluruBengaluruSELECTBIOenquiries@selectbiosciences.com
